CyTOF analysis identifies unusual immune cells in urine of BCG-treated bladder cancer patients

High grade non-muscle-invasive bladder tumours are treated with transurethral resection followed by recurrent intravesical instillations of Bacillus Calmette Guérin (BCG). Although most bladder cancer patients respond well to BCG, there is no clinical parameter predictive of treatment response, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Castellano, Eva, Samba, Célia, Esteso, Gloria, Simpson, Laura, Vendrame, Elena, García‐Cuesta, Eva M., López‐Cobo, Sheila, Álvarez-Maestro, Mario, Linares, Ana, Leibar, Asier, Ranganath, Thanmayi, Reyburn, Hugh T., Martínez‐Piñeiro, Luis, Blish, Catherine, Valés‐Gómez, Mar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520259/
https://www.ncbi.nlm.nih.gov/pubmed/36189320
http://dx.doi.org/10.3389/fimmu.2022.970931

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520259/
https://www.ncbi.nlm.nih.gov/pubmed/36189320
http://dx.doi.org/10.3389/fimmu.2022.970931

Ejemplares similares